Pubmed ID: 34876531

Pubmed Central ID: PMC8753761

Journal: Diabetes care

Publication Date: Jan. 1, 2022

Affiliation: 1MRC Population Health Research Unit, Clinical Trial Service Unit, and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, U.K.

MeSH Terms: Humans, Randomized Controlled Trials as Topic, Diabetes Mellitus, Hypolipidemic Agents, Diabetic Retinopathy, Fenofibrate, Lasers

Grants: MC_U137686853, MC_UU_12026/5, SP/08/010/25939, SP/14/3/31114

Authors: Preiss D, Lovato L, Ginsberg HN, Coleman RL, Holman RR, Spata E, Armitage J

Cite As: Preiss D, Spata E, Holman RR, Coleman RL, Lovato L, Ginsberg HN, Armitage J. Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials. Diabetes Care 2022 Jan 1;45(1):e1-e2.

Studies:

• Action to Control Cardiovascular Risk in Diabetes (ACCORD)